| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/28/2004 | EP1412377A1 Production of high molecular mass lectins |
| 04/28/2004 | EP1412375A2 Alteration of oil traits in plants |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412373A2 Alteration of oil traits in plants |
| 04/28/2004 | EP1412372A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 04/28/2004 | EP1411980A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 04/28/2004 | EP1411979A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/28/2004 | EP1411975A1 Methylation of histone h4 at arginine 3 |
| 04/28/2004 | EP1411974A2 Materials and methods relating to improved vaccination strategies |
| 04/28/2004 | EP1411971A1 Use of long pentraxin ptx3 for treating female infertility |
| 04/28/2004 | EP1411970A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/28/2004 | EP1411969A1 Modified protamine with reduced immunogenicity |
| 04/28/2004 | EP1411968A2 Glp-1 exendin-4 peptide analogs and uses thereof |
| 04/28/2004 | EP1411967A2 Blocking peptide for inflammatory cell secretion |
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411965A1 Methods and compositions for controlling protein assembly or aggregation |
| 04/28/2004 | EP1411964A2 Peptides which modulate blood coagulation and methods of use thereof |
| 04/28/2004 | EP1411963A2 Cytotoxic factors for modulating cell death |
| 04/28/2004 | EP1411880A2 Recombinant vsv for the treatment of tumor cells |
| 04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 04/28/2004 | EP1411762A2 Combinations of genes for producing seed plants exhibiting modulated reproductive development |
| 04/28/2004 | EP1411761A2 Metabolite transporters |
| 04/28/2004 | EP1326628B1 Chemokine mutants in the treatment of multiple sclerosis |
| 04/28/2004 | EP1286684B1 use of cxcr4 antagonists for treating autoimmune diseases and cancer |
| 04/28/2004 | EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 04/28/2004 | EP1061946B1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 04/28/2004 | EP1015484B1 Peptides derived from complement peptide c3a sequence and antiallergic compositions comprising them |
| 04/28/2004 | EP1012190A4 Eosinophil eotaxin receptor |
| 04/28/2004 | EP0944723B1 Mammalian chemokines |
| 04/28/2004 | EP0910642B1 A method for increasing hemoprotein production in filamentous fungi |
| 04/28/2004 | EP0840741B1 Pna-dna chimeras and pna synthons for their preparation |
| 04/28/2004 | EP0805822B1 Spray dried erythropoietin |
| 04/28/2004 | EP0799317B1 Method for secreting thrombopoietin polypeptides |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0730469B1 Modified truncated complement system regulators |
| 04/28/2004 | EP0698095B1 Bmp-10 compositions |
| 04/28/2004 | EP0626861B2 Treatment for asthma |
| 04/28/2004 | CN1493052A Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 04/28/2004 | CN1492929A Myocyte differentiation factor Fwa 267 |
| 04/28/2004 | CN1492928A Cell proliferation factor Fwap 10576 |
| 04/28/2004 | CN1492927A Human FGF23 protein mutant lowering blood phosphorus level |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/28/2004 | CN1492925A Rice sucrose transporter gene promoter |
| 04/28/2004 | CN1492923A 减毒的活疫苗 Attenuated live vaccine |
| 04/28/2004 | CN1492879A Protein tau |
| 04/28/2004 | CN1492768A Artificial proteins with reduced immunogenicity |
| 04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
| 04/28/2004 | CN1492038A Method for producing target material by fermentation |
| 04/28/2004 | CN1491964A Process for purifying hematoglobin |
| 04/28/2004 | CN1491963A Live scorpion active protein having anti-epilepsy function, preparing method and use |
| 04/28/2004 | CN1491962A Myb transcription factor of cotton and its encoding gene and use |
| 04/28/2004 | CN1491961A Amaranth seed ribosome inactivating protein |
| 04/28/2004 | CN1491960A Rice DREB transcription factor and its encoding gene and use |
| 04/28/2004 | CN1491624A Modified biological material |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CN1147294C Pentafluorobenzenesulfonamides and analogs |
| 04/27/2004 | US6727409 Active against lepidoptera |
| 04/27/2004 | US6727408 Polynucleotide which codes protein; for use in generating stress resistant cells |
| 04/27/2004 | US6727407 Shortening flowering time in plants |
| 04/27/2004 | US6727405 Transgenic animals secreting desired proteins into milk |
| 04/27/2004 | US6727355 Pharmaceutical composition for treatment of Duchenne muscular dystrophy |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727350 Toso |
| 04/27/2004 | US6727349 Recombinant anti-CCR2 antibodies and methods of use therefor |
| 04/27/2004 | US6727348 Compositions and methods for the diagnosis and treatment of body weight disorders, including obesity |
| 04/27/2004 | US6727346 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727224 Methods and compositions for healing and repair of articular cartilage |
| 04/27/2004 | US6727223 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 04/27/2004 | US6727222 Transcriptional regulator |
| 04/27/2004 | US6727093 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by cd8+ class i major histocompatibility complex restricted cytotoxic t-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 04/27/2004 | US6727092 Methods for the simultaneous detection of HCV antigens and HCV antibodies |
| 04/27/2004 | US6727086 Nucleotide sequences which code for the sigH gene |
| 04/27/2004 | US6727082 For identifying drugs that inhibit fungal gtpase activity, particularly those involved in cell wall integrity, hyphael formation and other functions critical to pathogenesis; isolated geranylgeranyl protein transferase |
| 04/27/2004 | US6727080 Monoclonal antibodies for use in cancer immunotherapy and their preparation; marker not restricted to previously defined histological classes of cancer |
| 04/27/2004 | US6727079 cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product |
| 04/27/2004 | US6727078 Genetic engineering; removal, insertion gene; lentivirus |
| 04/27/2004 | US6727077 Used for detecting and treating cancer |
| 04/27/2004 | US6727074 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 04/27/2004 | US6727063 Single nucleotide polymorphisms in genes |
| 04/27/2004 | US6727061 Methods for identifying species or Shigella and E. coli using operon sequence analysis |
| 04/27/2004 | US6727058 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 04/27/2004 | US6726912 Papillomavirus polyprotein constructs |
| 04/27/2004 | US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/27/2004 | US6726907 Purified adenoviral compositions |
| 04/27/2004 | CA2295999C Nik proteins, nucleic acids and methods |
| 04/27/2004 | CA2152166C Process for detecting fibrocystic desease or a cftr gene mutation |
| 04/27/2004 | CA2152047C Production of human recombinant collagen in the milk of transgenic animals |
| 04/27/2004 | CA2058370C Monoclonal antibodies against human tumor necrosis factor .alpha. |
| 04/25/2004 | CA2446662A1 Plasmodium falciparum virulence factor var o |
| 04/25/2004 | CA2409897A1 Plasmodium falciparum virulence factor var o |
| 04/22/2004 | WO2004034093A2 Caterpiller gene family |
| 04/22/2004 | WO2004034031A2 A method for diagnosis and prognosis of multiple sclerosis |
| 04/22/2004 | WO2004034029A2 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 04/22/2004 | WO2004033723A2 Neurodegenerative disease-associated gene |
| 04/22/2004 | WO2004033717A1 Autism gene |